<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07290008069212</udiDi>
    <basicUdiDi>B-07290008069212</basicUdiDi>
    <tradeName>BIOLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bio-Technology General (Israel) Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000003764</manufacturerSrn>
    <authorisedRepresentativeName>Ferring Pharmaceuticals A/S</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DK-AR-000001206</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6301182002</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T23:59:29.061Z</lastUpdated>
  </row>
  <row>
    <udiDi>07290008069182</udiDi>
    <basicUdiDi>B-07290008069182</basicUdiDi>
    <tradeName>BIOLON prime</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bio-Technology General (Israel) Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000003764</manufacturerSrn>
    <authorisedRepresentativeName>Ferring Pharmaceuticals A/S</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DK-AR-000001206</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6301182003</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T23:59:27.449Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640128548409</udiDi>
    <basicUdiDi>B-07640128548409</basicUdiDi>
    <tradeName>EUFLEXXA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bio-Technology General (Israel) Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000003764</manufacturerSrn>
    <authorisedRepresentativeName>Ferring Pharmaceuticals A/S</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DK-AR-000001206</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6301182061</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:59:42.693Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640128545545</udiDi>
    <basicUdiDi>B-07640128545545</basicUdiDi>
    <tradeName>EUFLEXXA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bio-Technology General (Israel) Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000003764</manufacturerSrn>
    <authorisedRepresentativeName>Ferring Pharmaceuticals A/S</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DK-AR-000001206</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6301182060</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:59:41.522Z</lastUpdated>
  </row>
</eudamedExport>